Penn Study Highlights Significant Side Effects Experienced by BRCA Mutation Carriers Following Cancer Risk-Reducing Surgical Procedure
The majority of women with cancer causing BRCA1 and BRCA2 mutations experience sexual dysfunction, menopausal symptoms, cognitive and stress issues, and poor sleep following prophylactic removal of their Fallopian tubes and ovaries - a procedure known as risk-reducing salpingo-oophorectomy (RRSO) - according to results of a new study from the Abram
President Amy Gutmann today announced the launch of the Penn Center for Innovation, a new initiative that will provide the infrastructure, leadership and resources needed to transfer promising Penn inventions, know-how and related assets into the marketplace for the public good.
Penn Study Shows Longest-lasting Cardiology Guidelines Built on Findings of Randomized Controlled Trials
Clinical practice guideline recommendations related to screening and treatment can change markedly over time as new evidence about best practices and clinical outcomes of various treatments emerges.
It’s smooth sailing ahead for one student-run club at the University of Pennsylvania.
Puberty is the defining process of adolescent development, beginning a cascade of changes throughout the body, including the brain.
In the largest group of results to date, researchers from Penn Medicine’s Abramson Cancer Center and other institutions have shown in clinical trials that the malaria drug hydroxychloroquine (HCQ) blocked autophagy in a host of aggressive cancers—glioblastoma, melanoma, lymphoma and myeloma, renal and colon cancers—and in some cases helped stabiliz
The Penn Medicine Center for Health Care Innovation will fund three new initiatives in the second round of its Innovation Grant Program. The program encourages Penn employees and students to submit their ideas for advancing health and health care delivery.
For undergraduate students who live on-campus in Stouffer College House at the University of Pennsylvania, a well-known advertising slogan for the frozen dinners that bear the same name rings true with its motto: Nihil Domo Similius, “Nothing comes closer to home.”
Penn President Amy Gutmann and Provost Vincent Price today announced that William Burke-White has been named the inaugural Richard Perry Professor and director of the Perry World House at the University of Pennsylvania.
May graduate Tania Chairez never planned to become an activist, but soon after she arrived at the University of Pennsylvania as a freshman, she found a new calling. Chairez became an advocate for undocumented residents of the United States.
Nearly half of all adults in the United States suffer from the gum disease periodontitis, and 8.5 percent have a severe form that can raise the risk of heart disease, diabetes, arthritis and pregnancy complications.
Racism and racial stereotyping still haunt America’s schools and foster academic underachievement, but “racial literacy” may pave the way toward better understanding and stronger, more successful students.
Penn Researcher Studies Effects of Common Anti-depressant on Brain Peptide Thought to be Responsible for the Development of Alzheimer's
A University of Pennsylvania researcher has discovered that the common selective serotonin reuptake inhibitor (SSRI) citalopram arrested the growth of amyloid beta, a peptide in the brain that clusters in plaques that are thought to trigger the development of Alzheimer’s disease (AD).
Penn Study Reveals Breastfeeding, Birth Control Pills May Reduce Ovarian Cancer Risk Among Women with BRCA Gene Mutations
Breastfeeding, tubal ligation – also known as having one’s “tubes tied” – and oral contraceptives may lower the risk of ovarian cancer for some women with BRCA gene mutations, according to a comprehensive analysis from a team at the University of Pennsylvania's Basser Research Center for BRCA and the
Study from Penn Medicine's Abramson Cancer Center Helps Dispel Commonly-Held Beliefs about Cancer Care and Patient Demands for Treatment
Despite claims suggesting otherwise, inappropriate cancer patient demands are few and very rarely lead to unnecessary tests and treatments from their health care providers, according to new results from a study that will be presented by researchers in the Abramson Cancer Center (ACC) and the Perelma
While large genetic testing panels promise to uncover clues about patients’ DNA, a team of researchers from Penn Medicine’s Abramson Cancer Center (ACC) has found that those powerful tests tend to produce more questions than they answer.
Studies of vaccine programs in the developing world have revealed that individuals with chronic infections such as malaria and hepatitis tend to be less likely to develop the fullest possible immunity benefits from vaccines for unrelated illnesses.
The body’s innate immune system is a first line of defense, intent on sensing invading pathogens and wiping them out before they can cause harm. It should not be surprising then that bacteria have evolved many ways to specifically evade and overcome this sentry system in order to spread infection.